US Patent Issued to Albert-Ludwigs-Universitat Freiburg on Oct. 20 for "Riboflavin for treating collagenous tissues in the diseases of joints, particularly of intervertebral discs" (German Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,149, issued on Oct. 20, was assigned to Albert-Ludwigs-Universitat Freiburg (Freiburg, Germany).

"Riboflavin for treating collagenous tissues in the diseases of joints, particularly of intervertebral discs" was invented by Ioannis Vasilikos (Freiburg, Germany) and Ulrich Hubbe (Freiburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Riboflavin for use as a medicament in the treatment of a patient with a disease of a diarthrotic, amphiarthrotic or synarthrotic joint, preferably an intervertebral disc disease is provided. The treatment occurs in situ in the patient and includes local administering of riboflavin in a collagenous tissue of the ...